Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients
Francesca Vendittelli, Marco Raffaelli, Guido Fadda, Cristiana Carelli Alinovi, Carmela Paolillo, Rocco Domenico Alfonso Bellantone, Cecilia Zuppi, Ettore Capoluongo
Dive into the research topics of 'Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients'. Together they form a unique fingerprint.